Role and mechanism of miR-222 in arsenic-transformed cells for inducing tumor growth

Oncotarget

Volumn 7, Issue 14, 2016, Pages 17805-17814

  Wang, Min ^a   Ge, Xin ^a   Zheng, Jitai ^a   Li, Dongmei ^a,d   Liu, Xue ^a   Wang, Lin ^a,d   Jiang, Chengfei ^a   Shi, Zhumei ^a   Qin, Lianju ^c   Liu, Jiayin ^c   Yang, Hushan ^e   Liu, Ling Zhi ^e   He, Jun ^e   Zhen, Linlin ^b   Jiang, Bing Hua ^a,e  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE AFFILIATED HUAIAN NO 1 PEOPLE S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^d Ninggao Personalized Medicine and Technology Innovation Center   (China)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

ARID1A; BEAS 2B cells; MiR 222; PTEN; Tumor growth

Indexed keywords

ARID1A PROTEIN; ARSENIC; CELL PROTEIN; MICRORNA 222; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; UNCLASSIFIED DRUG; MICRORNA; MIRN222 MICRORNA, HUMAN; PTEN PROTEIN, HUMAN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENE FUNCTION; HUMAN; HUMAN CELL; IN VIVO STUDY; LUNG ALVEOLUS EPITHELIUM; MOUSE; NONHUMAN; ONCOLOGICAL PARAMETERS; PROTEIN EXPRESSION; TUBE FORMATION; TUMOR GROWTH; TUMOR VOLUME; TUMOR WEIGHT; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; ARSENIC POISONING; BAGG ALBINO MOUSE; BIOSYNTHESIS; CHEMICALLY INDUCED; DRUG EFFECTS; GENETICS; LUNG TUMOR; METABOLISM; NUDE MOUSE; PATHOLOGY; RESPIRATORY MUCOSA; TRANSFORMED CELL LINE; TUMOR CELL LINE; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; APOPTOSIS; ARSENIC; ARSENIC POISONING; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; PTEN PHOSPHOHYDROLASE; RESPIRATORY MUCOSA; UP-REGULATION;

EID: 84975489418     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.7525     Document Type: Article

References (35)

1. Hubaux R, Becker-Santos DD, Enfield KS, Lam S, Lam WL, Martinez VD. Arsenic, asbestos and radon: emerging players in lung tumorigenesis. Environ Health. 2012; 11:89.
2. Huang L, Wu H, van der Kuijp TJ. The health effects of exposure to arsenic-contaminated drinking water: a review by global geographical distribution. International journal of environmental health research. 2014:1-21.
3. Hong YS, Song KH, Chung JY. Health effects of chronic arsenic exposure. Journal of preventive medicine and public health = Yebang Uihakhoe chi. 2014; 47:245-252.
4. Overall evaluations of carcinogenicity: an updating of IARC Monographs volumes 1 to 42. IARC Monogr Eval Carcinog Risks Hum Suppl. 1987; 7:1-440.
5. Romero-Cordoba SL, Salido-Guadarrama I, Rodriguez-Dorantes M, Hidalgo-Miranda A. miRNA biogenesis: Biological impact in the development of cancer. Cancer biology & therapy. 2014; 15:1444-1455.
6. Zhao L, Zhang Y. miR-342-3p affects hepatocellular carcinoma cell proliferation via regulating NF-kappaB pathway. Biochem Biophys Res Commun. 2015; 457:370-7.
7. Wang SH, Zhou JD, He QY, Yin ZQ, Cao K, Luo CQ. MiR-199a inhibits the ability of proliferation and migration by regulating CD44-Ezrin signaling in cutaneous squamous cell carcinoma cells. International journal of clinical and experimental pathology. 2014; 7:7131-7141.
8. Huang H, Sun P, Lei Z, Li M, Wang Y, Zhang HT, Liu J. miR-145 inhibits invasion and metastasis by directly targeting Smad3 in nasopharyngeal cancer. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2015.
9. Chun-Zhi Z, Lei H, An-Ling Z, Yan-Chao F, Xiao Y, Guang-Xiu W, Zhi-Fan J, Pei-Yu P, Qing-Yu Z, Chun-Sheng K. MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN. BMC cancer. 2010; 10:367.
10. Yang YF, Wang F, Xiao JJ, Song Y, Zhao YY, Cao Y, Bei YH, Yang CQ. MiR-222 overexpression promotes proliferation of human hepatocellular carcinoma HepG2 cells by downregulating p27. International journal of clinical and experimental medicine. 2014; 7:893-902.
11. Lu Y, Roy S, Nuovo G, Ramaswamy B, Miller T, Shapiro C, Jacob ST, Majumder S. Anti-microRNA-222 (antimiR-222) and-181B suppress growth of tamoxifenresistant xenografts in mouse by targeting TIMP3 protein and modulating mitogenic signal. J Biol Chem. 2011; 286:42292-42302.
12. Mao KP, Zhang WN, Liang XM, Ma YR. MicroRNA-222 expression and its prognostic potential in non-small cell lung cancer. The Scientific World Journal. 2014; 2014:908326.
13. Sharma D, Tiwari M, Lakhwani D, Tripathi RD, Trivedi PK. Differential expression of microRNAs by arsenate and arsenite stress in natural accessions of rice. Metallomics: integrated biometal science. 2015; 7:174-187.
14. Wang Z, Humphries B, Xiao H, Jiang Y, Yang C. MicroRNA-200b suppresses arsenic-transformed cell migration by targeting protein kinase Calpha and Wnt5bprotein kinase Calpha positive feedback loop and inhibiting Rac1 activation. J Biol Chem. 2014; 289:18373-18386.
15. Luo F, Ji J, Liu Y, Xu Y, Zheng G, Jing J, Wang B, Xu W, Shi L, Lu X, Liu Q. MicroRNA-21, up-regulated by arsenite, directs the epithelial-mesenchymal transition and enhances the invasive potential of transformed human bronchial epithelial cells by targeting PDCD4. Toxicol Lett. 2014; 232:301-309.
16. Liu LZ, Li C, Chen Q, Jing Y, Carpenter R, Jiang Y, Kung HF, Lai L, Jiang BH. MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1alpha expression. PloS one. 2011; 6:e19139.
17. He J, Wang M, Jiang Y, Chen Q, Xu S, Xu Q, Jiang BH, Liu LZ. Chronic arsenic exposure and angiogenesis in human bronchial epithelial cells via the ROS/miR-199a-5p/HIF-1alpha/COX-2 pathway. Environ Health Perspect. 2014; 122:255-261.
18. Qian X, Yu J, Yin Y, He J, Wang L, Li Q, Zhang LQ, Li CY, Shi ZM, Xu Q, Li W, Lai LH, Liu LZ, et al. MicroRNA-143 inhibits tumor growth and angiogenesis and sensitizes chemosensitivity to oxaliplatin in colorectal cancers. Cell cycle. 2013; 12:1385-1394.
19. Xie H, Huang S, Martin S, Wise JP, Sr. Arsenic is cytotoxic and genotoxic to primary human lung cells. Mutat Res. 2014; 760:33-41.
20. Boffetta P. Epidemiology of environmental and occupational cancer. Oncogene. 2004; 23:6392-6403.
21. Carpenter RL, Jiang Y, Jing Y, He J, Rojanasakul Y, Liu LZ, Jiang BH. Arsenite induces cell transformation by reactive oxygen species, AKT, ERK1/2, and p70S6K1. Biochem Biophys Res Commun. 2011; 414:533-538.
22. Liu F, Jan KY. DNA damage in arsenite-and cadmiumtreated bovine aortic endothelial cells. Free Radic Biol Med. 2000; 28:55-63.
23. Shi Q, Sutariya V, Bishayee A, Bhatia D. Sequential activation of Elk-1/Egr-1/GADD45alpha by arsenic. Oncotarget. 2014; 5:3862-3870. doi: 10.18632/oncotarget.1995.
24. Chang Q, Chen B, Thakur C, Lu Y, Chen F. Arsenic-induced sub-lethal stress reprograms human bronchial epithelial cells to CD61 cancer stem cells. Oncotarget. 2014; 5:1290-1303. doi: 10.18632/oncotarget.1789.
25. Beezhold K, Liu J, Kan H, Meighan T, Castranova V, Shi X, Chen F. miR-190-mediated downregulation of PHLPP contributes to arsenic-induced Akt activation and carcinogenesis. Toxicol Sci. 2011; 123:411-420.
26. Beezhold KJ, Castranova V, Chen F. Microprocessor of microRNAs: regulation and potential for therapeutic intervention. Mol Cancer. 2010; 9:134.
27. Zhang C, Zhang J, Zhang A, Wang Y, Han L, You Y, Pu P, Kang C. PUMA is a novel target of miR-221/222 in human epithelial cancers. International journal of oncology. 2010; 37:1621-1626.
28. Zhang Y, Yao J, Huan L, Lian J, Bao C, Li Y, Ge C, Li J, Yao M, Liang L, He X. GNAI3 inhibits tumor cell migration and invasion and is post-transcriptionally regulated by miR-222 in hepatocellular carcinoma. Cancer Lett. 2015; 356:978-984.
29. Wang S, Tie J, Wang R, Hu F, Gao L, Wang W, Wang L, Li Z, Hu S, Tang S, Li M, Wang X, Nie Y, et al. SOX2, a predictor of survival in gastric cancer, inhibits cell proliferation and metastasis by regulating PTEN. Cancer Lett. 2015; 358:210-9.
30. Shang Y, Guo XX, Li WW, Rao W, Chen ML, Mu LN, Li SJ. Cucurbitacin-B inhibits neuroblastoma cell proliferation through up-regulation of PTEN. European review for medical and pharmacological sciences. 2014; 18:3297-3303.
31. Jiang BH, Liu LZ. PI3K/PTEN signaling in angiogenesis and tumorigenesis. Advances in cancer research. 2009; 102:19-65.
32. Jin Y, Li Y, Pan L. The target therapy of ovarian clear cell carcinoma. OncoTargets and therapy. 2014; 7:1647-1652.
33. Lavorato-Rocha AM, Anjos LG, Cunha IW, Vassallo J, Soares FA, Rocha RM. Immunohistochemical assessment of PTEN in vulvar cancer: Best practices for tissue staining, evaluation, and clinical association. Methods. 2015; 77-78:20-4.
34. Nagymanyoki Z, Mutter GL, Hornick JL, Cibas ES. ARID1A is a useful marker of malignancy in peritoneal washings for endometrial carcinoma. Cancer cytopathology. 2015; 123:253-7.
35. Samartzis EP, Gutsche K, Dedes KJ, Fink D, Stucki M, Imesch P. Loss of ARID1A expression sensitizes cancer cells to PI3K-and AKT-inhibition. Oncotarget. 2014; 5:5295-5303. doi: 10.18632/oncotarget.2092.